KCAS will be attending the PBSS Workshop: Distribution and Disposition Studies for Biotherapeutics: Multi-specific Antibodies, ADCs, Peptide Conjugates, Cell Therapies and Protein Degrader.  

Advanced biologics and protein engineering enable the development of novel biotherapeutic modalities to treat critical disease-relevant targets. Distribution and disposition of small molecules is intensively investigated during drug discovery and development stages. In contrast, biotransformation of next generation modalities such as multispecifics, Antibody Drug Conjugates (ADCs), nucleotides, peptide conjugates, and protein degraders has not been extensively explored. This workshop will cover this diverse topic of next-generation novel biotherapeutics and provide an opportunity for the community to discuss the technical aspect, role and impact of distribution and disposition on the development of novel modalities.

MEET US AT THIS EVENT